Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Invesco S&P SmallCap Low Volatility ETF
XSLV
$248M
| $2.36M | ﹤0.01% |
55,100
+546
| +1% | +$23.4K |
|
3527
Kearny Financial
KRNY
$604M
| $2.36M | ﹤0.01% |
156,900
+66,485
| +74% | +$1M |
|
|
OMED
3528
PUT
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.36M | ﹤0.01% |
+256,300
| New | +$2.25M |
|
|
HSII
3529
DELISTED
Heidrick & Struggles
HSII
| $2.36M | ﹤0.01% |
89,563
-40,382
| -31% | -$949K |
|
3530
Corcept Therapeutics
CORT
$12.4B
| $2.36M | ﹤0.01% |
215,292
+83,026
| +63% | +$729K |
|
|
NTUS
3531
DELISTED
Natus Medical Inc
NTUS
| $2.36M | ﹤0.01% |
60,017
-72,615
| -55% | -$2.72M |
|
|
FSP
3532
Franklin Street Properties
FSP
$47.2M
| $2.35M | ﹤0.01% |
193,386
-55,654
| -22% | -$689K |
|
3533
Super Micro Computer
SMCI
$18.4B
| $2.35M | ﹤0.01% |
925,610
-1,088,780
| -54% | -$2.89M |
|
3534
Dine Brands
DIN
$456M
| $2.34M | ﹤0.01% |
43,017
-1,093
| -2% | -$69K |
|
3535
PUT
Penumbra
PEN
$12.7B
| $2.34M | ﹤0.01% |
28,000
| – | – |
|
|
ATW
3536
DELISTED
Atwood Oceanics
ATW
| $2.33M | ﹤0.01% |
245,061
-43,728
| -15% | -$488K |
|
3537
CALL
TripAdvisor
TRIP
$1.65B
| $2.33M | ﹤0.01% |
54,000
-35,500
| -40% | -$1.68M |
|
|
RAVN
3538
DELISTED
Raven Industries Inc
RAVN
| $2.33M | ﹤0.01% |
80,212
+5,086
| +7% | +$138K |
|
|
ITG
3539
DELISTED
Investment Technology Group Inc
ITG
| $2.33M | ﹤0.01% |
115,003
-7,571
| -6% | -$153K |
|
|
FINL
3540
PUT
DELISTED
Finish Line
FINL
| $2.33M | ﹤0.01% |
+163,700
| New | +$2.75M |
|
|
NXEO
3541
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $2.33M | ﹤0.01% |
262,779
+66,588
| +34% | +$615K |
|
3542
City Holding Co
CHCO
$2.05B
| $2.33M | ﹤0.01% |
36,053
-15,766
| -30% | -$1.03M |
|
3543
Q2 Holdings
QTWO
$3.8B
| $2.32M | ﹤0.01% |
66,631
+42,136
| +172% | +$1.4M |
|
|
MDCO
3544
CALL
DELISTED
Medicines Co
MDCO
| $2.32M | ﹤0.01% |
47,500
-144,700
| -75% | -$6.6M |
|
|
HAPN
3545
PUT
Happen Inc
HAPN
$2.21B
| $2.32M | ﹤0.01% |
84,540
-56,080
| -40% | -$1.59M |
|
|
DYN
3546
DELISTED
Dynegy, Inc.
DYN
| $2.32M | ﹤0.01% |
294,778
-1,492,825
| -84% | -$12.8M |
|
3547
CALL
Adtran
ADTN
$689M
| $2.31M | ﹤0.01% |
111,500
+78,300
| +236% | +$1.7M |
|
3548
MannKind Corp
MNKD
$1.21B
| $2.31M | ﹤0.01% |
1,562,405
+21,943
| +1% | +$57.6K |
|
3549
PUT
Sturm, Ruger & Co
RGR
$594M
| $2.31M | ﹤0.01% |
43,100
+23,000
| +114% | +$1.18M |
|
3550
HUB Group
HUBG
$2.85B
| $2.31M | ﹤0.01% |
99,434
-17,412
| -15% | -$411K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.